Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Neurocrine Biosciences, Inc. NBIX

Full chart Compare
Set alert

Price alert · NBIX

All alert types
166.05 USD +1.20 (+0.73%)

At closeNov 4, 2026, 5:03 PM EST

166.05 0.00 0.00%

After hours · Nov 4, 5:03 PM ET

162.02 Day range 169.00
122.14 52-week range 186.12
YTD
+17.08%
1 year
+15.96%

Financial health

Altman Z-Score

7.34 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

A4 / 5 overall

  • DCF 5
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 3
  • P/E 3
  • P/B 2

Valuation

P/E 29.5×
FY 2016: -23.7×FY 2017: -47.9×FY 2018: 325×FY 2019: 269×FY 2020: 21.9×FY 2021: 89.7×FY 2022: 74.2×FY 2023: 51.5×FY 2024: 40.1×FY 2025: 29.5×
FY 2016 5y median 51.5× FY 2025
P/S 4.9×
FY 2016: 223×FY 2017: 42.2×FY 2018: 15.1×FY 2019: 12.5×FY 2020: 8.5×FY 2021: 7.1×FY 2022: 7.7×FY 2023: 6.8×FY 2024: 5.8×FY 2025: 4.9×
FY 2016 5y median 6.8× FY 2025
P/B 4.3×
FY 2016: 10.6×FY 2017: 18.3×FY 2018: 14.2×FY 2019: 15.5×FY 2020: 7.9×FY 2021: 5.9×FY 2022: 6.7×FY 2023: 5.8×FY 2024: 5.3×FY 2025: 4.3×
FY 2016 5y median 5.8× FY 2025
P/FCF 18.8×
FY 2016: -30.4×FY 2017: -67.4×FY 2018: 88.9×FY 2019: 74.4×FY 2020: 41.0×FY 2021: 34.6×FY 2022: 35.4×FY 2023: 35.6×FY 2024: 24.6×FY 2025: 18.8×
FY 2016 5y median 34.6× FY 2025
EV/EBITDA 20.7×
FY 2016: -23.4×FY 2017: -57.6×FY 2018: 125×FY 2019: 119×FY 2020: 61.8×FY 2021: 59.1×FY 2022: 48.4×FY 2023: 31.4×FY 2024: 21.8×FY 2025: 20.7×
FY 2016 5y median 31.4× FY 2025
EV/Sales 4.8×
FY 2016: 218×FY 2017: 43.0×FY 2018: 15.6×FY 2019: 13.0×FY 2020: 8.7×FY 2021: 7.2×FY 2022: 7.7×FY 2023: 6.9×FY 2024: 5.9×FY 2025: 4.8×
FY 2016 5y median 6.9× FY 2025
FCF Yield 5.3%
FY 2016: -3.3%FY 2017: -1.5%FY 2018: 1.1%FY 2019: 1.3%FY 2020: 2.4%FY 2021: 2.9%FY 2022: 2.8%FY 2023: 2.8%FY 2024: 4.1%FY 2025: 5.3%
FY 2016 5y median 2.9% FY 2025

Profitability

Gross Margin 98.2%
FY 2016: 100.0%FY 2017: 99.2%FY 2018: 98.9%FY 2019: 99.1%FY 2020: 99.0%FY 2021: 98.7%FY 2022: 98.4%FY 2023: 97.9%FY 2024: 98.6%FY 2025: 98.2%
FY 2016 5y median 98.4% FY 2025
Operating Margin 21.6%
FY 2016: -982.5%FY 2017: -81.3%FY 2018: 8.2%FY 2019: 9.2%FY 2020: 15.6%FY 2021: 9.0%FY 2022: 16.7%FY 2023: 13.3%FY 2024: 24.2%FY 2025: 21.6%
FY 2016 5y median 16.7% FY 2025
Net Margin 16.7%
FY 2016: -940.6%FY 2017: -88.2%FY 2018: 4.7%FY 2019: 4.7%FY 2020: 38.9%FY 2021: 7.9%FY 2022: 10.4%FY 2023: 13.2%FY 2024: 14.5%FY 2025: 16.7%
FY 2016 5y median 13.2% FY 2025
ROE 14.7%
FY 2016: -44.8%FY 2017: -38.3%FY 2018: 4.4%FY 2019: 5.8%FY 2020: 36.2%FY 2021: 6.5%FY 2022: 9.0%FY 2023: 11.2%FY 2024: 13.2%FY 2025: 14.7%
FY 2016 5y median 11.2% FY 2025
ROIC 10.8%
FY 2016: -44.0%FY 2017: -17.2%FY 2018: 3.9%FY 2019: 5.0%FY 2020: 10.5%FY 2021: 5.0%FY 2022: 9.0%FY 2023: 6.8%FY 2024: 12.5%FY 2025: 10.8%
FY 2016 5y median 9.0% FY 2025
ROA 10.3%
FY 2016: -38.6%FY 2017: -17.4%FY 2018: 2.1%FY 2019: 2.8%FY 2020: 23.5%FY 2021: 4.3%FY 2022: 6.5%FY 2023: 7.7%FY 2024: 9.2%FY 2025: 10.3%
FY 2016 5y median 7.7% FY 2025

Growth (YoY)

Revenue 21.4%
FY 2016: -24.1%FY 2017: 977.5%FY 2018: 179.2%FY 2019: 74.7%FY 2020: 32.7%FY 2021: 8.4%FY 2022: 31.3%FY 2023: 26.8%FY 2024: 24.8%FY 2025: 21.4%
FY 2016 FY 2025
Operating Income 8.5%
FY 2016: -56.4%FY 2017: 10.9%FY 2018: 128.0%FY 2019: 96.5%FY 2020: 125.4%FY 2021: -37.1%FY 2022: 142.9%FY 2023: 0.8%FY 2024: 127.4%FY 2025: 8.5%
FY 2016 FY 2025
EPS (diluted) 41.9%
FY 2016: -55.2%FY 2017: 0.6%FY 2018: 113.6%FY 2019: 77.3%FY 2020: 966.7%FY 2021: -77.9%FY 2022: 69.6%FY 2023: 58.3%FY 2024: 33.2%FY 2025: 41.9%
FY 2016 FY 2025
Free Cash Flow 34.4%
FY 2016: -176.2%FY 2017: 8.2%FY 2018: 175.6%FY 2019: 72.7%FY 2020: 64.5%FY 2021: 7.1%FY 2022: 38.5%FY 2023: 12.0%FY 2024: 54.1%FY 2025: 34.4%
FY 2016 FY 2025

Financial Health

Current Ratio 3.4×
FY 2016: 10.2×FY 2017: 10.2×FY 2018: 8.4×FY 2019: 1.5×FY 2020: 5.4×FY 2021: 4.0×FY 2022: 2.7×FY 2023: 2.5×FY 2024: 3.4×FY 2025: 3.4×
FY 2016 5y median 3.4× FY 2025
Quick Ratio 3.3×
FY 2016: 10.2×FY 2017: 10.2×FY 2018: 8.2×FY 2019: 1.4×FY 2020: 5.3×FY 2021: 3.8×FY 2022: 2.6×FY 2023: 2.4×FY 2024: 3.3×FY 2025: 3.3×
FY 2016 5y median 3.3× FY 2025
Debt / Equity 0.1×
FY 2016: 0.0×FY 2017: 1.0×FY 2018: 0.8×FY 2019: 0.8×FY 2020: 0.4×FY 2021: 0.3×FY 2022: 0.2×FY 2023: 0.2×FY 2024: 0.2×FY 2025: 0.1×
FY 2016 5y median 0.2× FY 2025
Net Debt / EBITDA -0.4×
FY 2016: 0.6×FY 2017: -1.0×FY 2018: 4.4×FY 2019: 4.5×FY 2020: 1.5×FY 2021: 0.7×FY 2022: 0.0×FY 2023: 0.4×FY 2024: 0.3×FY 2025: -0.4×
FY 2016 5y median 0.3× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: -6.7×FY 2018: 1.2×FY 2019: 2.3×FY 2020: 5.0×FY 2021: 4.0×FY 2022: 35.1×FY 2023: 54.5×FY 2024: 4.5×FY 2025: 0.0×
FY 2016 5y median 4.5× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31